Infrastructure Requirements for Human Papillomavirus Vaccination and Cervical Cancer Screening in Sub-Saharan Africa
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Achieving high coverage in Rwanda’s national human papillomavirus vaccination programmeBulletin of the World Health Organization, 2012
- Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countriesBulletin of the World Health Organization, 2011
- Clinical trials of cancer screening in the developing world and their impact on cancer healthcareAnnals of Oncology, 2011
- Human papillomavirus, cancer and vaccinationCurrent Opinion in HIV and AIDS, 2011
- Financing HPV vaccination in developing countriesThe Lancet, 2011
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Changing cancer incidence in Kampala, Uganda, 1991–2006International Journal of Cancer, 2009
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999